Array Biopharma, Inc. (ARRY) Reports Q2 Loss of 17c/Share
Tweet
Share
E-mailGet Alerts ARRY Hot Sheet
Price: $4.07 --0%
Revenue Growth %: -16.4%
Financial Fact:
Weighted average shares outstanding - basic (in shares): 145.1M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: -16.4%
Financial Fact:
Weighted average shares outstanding - basic (in shares): 145.1M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Array Biopharma, Inc. (NASDAQ: ARRY) reported Q2 EPS of ($0.17), $0.10 better than the analyst estimate of ($0.27).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Array Technologies (ARRY) PT Lowered to $6 at Baird
- AutoZone (AZO) Tops Q4 EPS by $1.76, Misses on Revenue
- AutoZone beats profit view but misses on revenue
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
